2008
DOI: 10.1097/gme.0b013e31815879df
|View full text |Cite
|
Sign up to set email alerts
|

Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women

Abstract: Objective-To examine the relationship of human immunodeficiency virus (HIV) and attribution of menopausal symptoms.Design-Peri-and postmenopausal women participating in a prospective study of HIV-infected and at-risk midlife women (the Ms. Study) were interviewed to determine whether they experienced hot flashes and/or vaginal dryness and to what they attributed these symptoms.Results-Of 278 women, 70% were perimenopausal; 54% were HIV-infected; and 52% had used crack, cocaine, heroin, and/or methadone within … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(33 citation statements)
references
References 30 publications
0
32
0
Order By: Relevance
“…Smoking and illicit substance use has been shown to influence the presence and/or severity of hot flashes in prior studies among non-HIV-infected women 3032 . In a study among menopausal HIV-infected and non-HIV-infected drug using women, a higher prevalence of hot flashes was observed among the HIV-infected women 20 .…”
Section: Discussionmentioning
confidence: 95%
“…Smoking and illicit substance use has been shown to influence the presence and/or severity of hot flashes in prior studies among non-HIV-infected women 3032 . In a study among menopausal HIV-infected and non-HIV-infected drug using women, a higher prevalence of hot flashes was observed among the HIV-infected women 20 .…”
Section: Discussionmentioning
confidence: 95%
“…Menopause was defined as having had the last menstrual period 1 year or more before enrollment in this study. 13 The results of CD4 count and HIV-RNA before HAART and history of HAART were extracted from medical records. Plasma HIV-1 RNA was determined using the CobasAmpliprep/TaqMan HIV-l Viral load assay (Roche Molecular Systems Inc., Branchburg, NJ).…”
Section: Methodsmentioning
confidence: 99%
“…Physiological and immunological manifestations associated with the natural aging process may also heighten the risk for HIV in midlife/older women (Johnson et al, 2008; Minkin, 2010). During menopause, women experience reductions in reproductive hormone levels (e.g., estrogen, progesterone) that physically alter sex organs (e.g., vaginal dryness, reduced vaginal canal elasticity, thinning vaginal mucosa), increasing midlife/older women’s risk for vaginal tearing and abrasions during intercourse (Bachmann & Leiblum, 2004; Minkin, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Though the definition of midlife/older women varies in the scientific community, the current study uses 45 years as the age cut-off, the average age of perimenopause when immunologic and physiological changes arise (Johnson et al, 2008; Neundorfer et al, 2005). Utilizing emergent themes from qualitative data and review of the literature, we hypothesized that midlife/older MA-using women (ages 45+) with experiences of PV will show no difference in sexual risk behaviors when compared to younger women (ages 18–44).…”
Section: Introductionmentioning
confidence: 99%